Redenlab
PrivateLast Round
Grant
Sep 22, 2025
Total Funding Raised
$1.64M
Company Overview
Redenlab is a health technology company that provides speech and language biomarker analysis to enhance decision-making in clinical trials and healthcare research.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Biotechnology, NLP & Conversational AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Redenlab Comparables
Compare Redenlab with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ki:elements GmbH | 89% | |
| Novoic | 85% | |
| Cumulus Neuroscience | 84% | |
Redenlab Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 22, 2025 |
Key People
Founding team and executive leadership
Redenlab Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CUREator | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2025
Monthly visitors increased 57% MoM.
- Jan 21, 2025
Grew 16% QoQ, from 25 to 29 employees.
Redenlab Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Redenlab's valuation, stock price, and market status.